Photochemotherapy for psoriasis
- 1 December 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 113 (12) , 1667-1670
- https://doi.org/10.1001/archderm.113.12.1667
Abstract
Photochemotherapy for psoriasis combining orally administered methoxsalen and long-wave UV (UVA) light was used in 186 patients with severe psoriasis. Several different phototherapy units with various numbers of high-output black lights were used. Excellent (90-100% clear) and good (80-90% clear) results were obtained in 77% of the patients. The average UVA dose at clearing was between 7 and 8 J/cm2. The majority of patients required 1 weekly maintenance UVA dose of their last clearing dose (J/cm2) to remain clear. Side effects and abnormal laboratory findings were minimal.This publication has 6 references indexed in Scilit:
- Photochemotherapy for psoriasis with orally administered methoxsalenArchives of Dermatology, 1976
- Abnormal Cell Proliferation in Psoriasis**From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida.Journal of Investigative Dermatology, 1968
- Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligoArchives of Dermatology, 1966
- Part IV: Basic Considerations of the Psoralens: Clinical and Laboratory Tolerance Studies in Volunteers Given Oral MethoxsalenJournal of Investigative Dermatology, 1959
- THE EFFECT OF OXYPSORALEN UPON ULTRAVIOLET CARCINOGENESIS IN ALBINO MICE1957
- Clinical and Experimental Studies with 8-Methoxypsoralen in Vitiligo1Journal of Investigative Dermatology, 1953